ClinicalTrialsFinder

Carcinoma, Non-Small-Cell Lung Cancer Clinical Trials in Shanghai

1 recruitingShanghai, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)Unresectable Stage III Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China43 enrolled1 locationNCT07408635